Found: 22
Select item for more details and to access through your institution.
Acute Promyelocytic Leukemia: an Experience on 95 Greek Patients Treated in the All-Trans-Retinoic Acid Era.
- Published in:
- Mediterranean Journal of Hematology & Infectious Diseases, 2011, v. 3, n. 1, p. 1, doi. 10.4084/MJHID.2011.053
- By:
- Publication type:
- Article
Frailty subgroup analysis of isatuximab with pomalidomide and dexamethasone in a UK‐wide real‐world cohort of relapsed myeloma patients.
- Published in:
- British Journal of Haematology, 2023, v. 201, n. 1, p. 162, doi. 10.1111/bjh.18672
- By:
- Publication type:
- Article
Expression of the novel tumour suppressor sterile alpha motif and HD domain‐containing protein 1 is an independent adverse prognostic factor in classical Hodgkin lymphoma.
- Published in:
- British Journal of Haematology, 2021, v. 193, n. 3, p. 488, doi. 10.1111/bjh.17352
- By:
- Publication type:
- Article
Myeloma clinical outcomes following the first wave of COVID‐19: results from the Thames Valley Cancer Alliance (UK).
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 6, p. e136, doi. 10.1111/bjh.17261
- By:
- Publication type:
- Article
Long term outcomes in monoclonal gammopathy of renal significance.
- Published in:
- British Journal of Haematology, 2019, v. 186, n. 5, p. 706, doi. 10.1111/bjh.15987
- By:
- Publication type:
- Article
Serological normalisation as a surrogate marker for minimal residual disease negativity in multiple myeloma.
- Published in:
- British Journal of Haematology, 2019, v. 185, n. 4, p. 775, doi. 10.1111/bjh.15615
- By:
- Publication type:
- Article
Resource implications of bortezomib therapy in a large UK cohort: An evaluation study.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 8, p. 1995, doi. 10.1177/1078155219866500
- By:
- Publication type:
- Article
Leukemic form of high-grade B-cell lymphoma (HGBL) in a very elderly patient with multiple comorbidities: effective treatment of a very rare subtype with a mini-R-da-EPOCH version.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 8, p. 2279, doi. 10.1007/s00277-023-05214-5
- By:
- Publication type:
- Article
Prognostic Impact of Serum β 2 -Microglobulin Levels in Hodgkin Lymphoma Treated with ABVD or Equivalent Regimens: A Comprehensive Analysis of 915 Patients.
- Published in:
- Cancers, 2024, v. 16, n. 2, p. 238, doi. 10.3390/cancers16020238
- By:
- Publication type:
- Article
Efficacy and tolerability of VCD chemotherapy in a UK real‐world dataset of elderly transplant‐ineligible newly diagnosed myeloma patients.
- Published in:
- European Journal of Haematology, 2021, v. 106, n. 4, p. 563, doi. 10.1111/ejh.13588
- By:
- Publication type:
- Article
Myeloma care adaptations in the UK during SARS‐CoV‐2 pandemic: Challenges and measurable outcomes.
- Published in:
- European Journal of Haematology, 2020, v. 105, n. 5, p. 662, doi. 10.1111/ejh.13479
- By:
- Publication type:
- Article
DPACE‐based chemotherapy in the era of myeloma novel agents: A UK multicentre study.
- Published in:
- European Journal of Haematology, 2020, v. 105, n. 2, p. 231, doi. 10.1111/ejh.13422
- By:
- Publication type:
- Article
Testing and management for monoclonal gammopathy of uncertain significance and myeloma patients presenting with osteoporosis and fragility fractures.
- Published in:
- Rheumatology, 2019, v. 58, n. 7, p. 1142, doi. 10.1093/rheumatology/kez127
- By:
- Publication type:
- Article
Consolidation following DPACE therapy improves outcomes in relapsed/refractory myeloma patients in the era of novel agents.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e254, doi. 10.1016/j.clml.2019.09.421
- By:
- Publication type:
- Article
Long Term Outcomes in Monoclonal Gammopathy of Renal Significance (MGRS).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e24, doi. 10.1016/j.clml.2017.03.042
- By:
- Publication type:
- Article
Proteasome Inhibitor Based Induction Improves Outcomes Only in Transplant Eligible NDMM Patients.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e123, doi. 10.1016/j.clml.2017.03.223
- By:
- Publication type:
- Article
Total Dose But Not Combination of Bortezomib Regimen Influences Outcomes in Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e78, doi. 10.1016/j.clml.2017.03.141
- By:
- Publication type:
- Article
To Treat or not to Treat: Hyperelderly Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e138, doi. 10.1016/j.clml.2017.03.249
- By:
- Publication type:
- Article
Incidence and risk factors for central nervous system relapse in patients with primary mediastinal large B‐cell lymphoma in the rituximab era.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 1, p. 97, doi. 10.1002/hon.3096
- By:
- Publication type:
- Article
Evaluation of the frailty characteristics and clinical outcomes according to the new frailty-based outcome prediction model (Myeloma Risk Profile-MRP) in a UK real-world cohort of elderly newly diagnosed Myeloma patients.
- Published in:
- PLoS ONE, 2022, v. 17, n. 1, p. 1, doi. 10.1371/journal.pone.0262388
- By:
- Publication type:
- Article
Identification of Very Low‐Risk Subgroups of Patients with Primary Mediastinal Large B‐Cell Lymphoma Treated with R‐CHOP.
- Published in:
- Oncologist, 2021, v. 26, n. 7, p. 597, doi. 10.1002/onco.13789
- By:
- Publication type:
- Article
Effect of splenectomy on type-1/type-2 cytokine gene expression a patient with adult idiopathic thrombocytopenic purpura (ITP).
- Published in:
- BMC Blood Disorders, 2004, v. 4, p. 4
- By:
- Publication type:
- Article